Agios Pharmaceuticals

Agios Pharmaceuticals company information, Employees & Contact Information

Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.

Company Details

Employees
654
Founded
-
Address
88 Sidney Street, Cambridge,ma 02139,united States
Phone
(617) 649-8600
Email
in****@****ios.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
agios.com
HQ
Cambridge, MA
Looking for a particular Agios Pharmaceuticals employee's phone or email?

Agios Pharmaceuticals Questions

News

Agios Pharmaceuticals to Host Conference Call for Q3 2025 Financial Results and Business Highlights - Quiver Quantitative

Agios Pharmaceuticals to Host Conference Call for Q3 2025 Financial Results and Business Highlights Quiver Quantitative

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET - GlobeNewswire

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET GlobeNewswire

CHMP Issues Positive Opinion for PYRUKYND — Agios advances treatment for adults with thalassemia - Stock Titan

CHMP Issues Positive Opinion for PYRUKYND — Agios advances treatment for adults with thalassemia Stock Titan

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm - Business Wire

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm Business Wire

Agios Pharmaceuticals Receives Positive CHMP Opinion for PYRUKYND® Indication in Thalassemia Treatment - Quiver Quantitative

Agios Pharmaceuticals Receives Positive CHMP Opinion for PYRUKYND® Indication in Thalassemia Treatment Quiver Quantitative

Agios Appoints Dr. Jay Backstrom To Board - citybiz

Agios Appoints Dr. Jay Backstrom To Board citybiz

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 | AGIO Stock News - GuruFocus

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 | AGIO Stock News GuruFocus

Earnings call transcript: Agios Pharm Q4 2024 beats EPS forecast, stock rises - Investing.com

Earnings call transcript: Agios Pharm Q4 2024 beats EPS forecast, stock rises Investing.com

Rare Disease Leader Agios Sets Q2 Earnings Call: Key Updates Expected on PK Activation Therapies - Stock Titan

Rare Disease Leader Agios Sets Q2 Earnings Call: Key Updates Expected on PK Activation Therapies Stock Titan

Agios Pharmaceuticals to Host Conference Call on Second Quarter 2025 Financial Results and Business Highlights - Quiver Quantitative

Agios Pharmaceuticals to Host Conference Call on Second Quarter 2025 Financial Results and Business Highlights Quiver Quantitative

Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET - The Manila Times

Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET The Manila Times

FDA Extends Review of First Oral Treatment for Thalassemia: Agios' PYRUKYND Decision Set for December - Stock Titan

FDA Extends Review of First Oral Treatment for Thalassemia: Agios' PYRUKYND Decision Set for December Stock Titan

Agios Pharmaceuticals Appoints Dr. Jay Backstrom to Board of Directors - Quiver Quantitative

Agios Pharmaceuticals Appoints Dr. Jay Backstrom to Board of Directors Quiver Quantitative

Agios Pharmaceuticals addresses analyst report on PYRUKYND safety data - Investing.com

Agios Pharmaceuticals addresses analyst report on PYRUKYND safety data Investing.com

AGIO STOCKHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire

AGIO STOCKHOLDER ALERT: Kaskela Law LLC Announces GlobeNewswire

Agios Pharmaceuticals’ SWOT analysis: FDA delay impacts stock outlook - Investing.com

Agios Pharmaceuticals’ SWOT analysis: FDA delay impacts stock outlook Investing.com

Agios Pharmaceuticals appoints Jay Backstrom to board of directors - Investing.com

Agios Pharmaceuticals appoints Jay Backstrom to board of directors Investing.com

European regulators back Agios’ thalassemia treatment - Investing.com

European regulators back Agios’ thalassemia treatment Investing.com

Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia - Business Wire

Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia Business Wire

Mitapivat Achieves Phase 3 Endpoint in Non-Transfusion-Dependent Thalassemia - HCPLive

Mitapivat Achieves Phase 3 Endpoint in Non-Transfusion-Dependent Thalassemia HCPLive

Servier to Acquire Agios Pharmaceuticals' Oncology Business - PR Newswire

Servier to Acquire Agios Pharmaceuticals' Oncology Business PR Newswire

Agios Pharmaceuticals’ Earnings Call Highlights Growth and Challenges - TipRanks

Agios Pharmaceuticals’ Earnings Call Highlights Growth and Challenges TipRanks

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND in Rare Blood Disorders - Business Wire

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND in Rare Blood Disorders Business Wire

Agios Pharma’s PYRUKYND Approved by Saudi Authority - TipRanks

Agios Pharma’s PYRUKYND Approved by Saudi Authority TipRanks

Agios Announces FDA Approval of PYRUKYND® (mitapivat) as - GlobeNewswire

Agios Announces FDA Approval of PYRUKYND® (mitapivat) as GlobeNewswire

Agios Appoints Cecilia Jones as Chief Financial Officer - GlobeNewswire

Agios Appoints Cecilia Jones as Chief Financial Officer GlobeNewswire

Agios Appoints Tsveta Milanova as Chief Commercial Officer - citybiz

Agios Appoints Tsveta Milanova as Chief Commercial Officer citybiz

Mitapivat phase 3 data clinically meaningful for children 1 to - Contemporary Pediatrics

Mitapivat phase 3 data clinically meaningful for children 1 to Contemporary Pediatrics

FDA Grants Orphan Drug Status to Mitapivat for Thalassemia - Medical Professionals Reference

FDA Grants Orphan Drug Status to Mitapivat for Thalassemia Medical Professionals Reference

Agios Pharm earnings missed by $0.12, revenue topped estimates - Investing.com

Agios Pharm earnings missed by $0.12, revenue topped estimates Investing.com

FDA approves Pyrukynd for adults with pyruvate kinase deficiency-related hemolytic anemia - Healio

FDA approves Pyrukynd for adults with pyruvate kinase deficiency-related hemolytic anemia Healio

Agios stock rises on European distribution deal By Investing.com - Investing.com Nigeria

Agios stock rises on European distribution deal By Investing.com Investing.com Nigeria

Tibsovo Approved to Treat Newly Diagnosed AML With IDH1 Mutation - Hematology Advisor

Tibsovo Approved to Treat Newly Diagnosed AML With IDH1 Mutation Hematology Advisor

Earnings call transcript: Agios Pharm Q2 2025 sees 45% revenue jump - Investing.com Australia

Earnings call transcript: Agios Pharm Q2 2025 sees 45% revenue jump Investing.com Australia

The Enduring Legacy of Saint George in Greece - GreekReporter.com

The Enduring Legacy of Saint George in Greece GreekReporter.com

Agios Efstratios becomes Greece’s first fully green, energy autonomous island - eKathimerini.com

Agios Efstratios becomes Greece’s first fully green, energy autonomous island eKathimerini.com

Agios Panteleimonas • Religious building - Outdooractive

Agios Panteleimonas • Religious building Outdooractive

Easter in Agios Nikolaos - eKathimerini.com

Easter in Agios Nikolaos eKathimerini.com

Copper Pendant, Workshops Found at Agios Sozomenos Site on Cyprus - GreekReporter.com

Copper Pendant, Workshops Found at Agios Sozomenos Site on Cyprus GreekReporter.com

Agios Pharmaceuticals Inc (AGIO) Stock Price, Trades & News - GuruFocus

Agios Pharmaceuticals Inc (AGIO) Stock Price, Trades & News GuruFocus

Large wildfire breaks out on Lefkada, one settlement evacuated - eKathimerini.com

Large wildfire breaks out on Lefkada, one settlement evacuated eKathimerini.com

IDH1 and IDH2 inhibitors | Cancer Biology - TLTC Blogs

IDH1 and IDH2 inhibitors | Cancer Biology TLTC Blogs

Captivating Byzantine concert fills Amorgos’ Agios Georgios Church - eKathimerini.com

Captivating Byzantine concert fills Amorgos’ Agios Georgios Church eKathimerini.com

Lefkada's Agios Nikolaos: The Dream Islet Reminiscent of the Caribbean - GreekReporter.com

Lefkada's Agios Nikolaos: The Dream Islet Reminiscent of the Caribbean GreekReporter.com

Agios Emilianos: Peloponnese's Riviera Offers Stunning Resorts and Villas (video) - GreekReporter.com

Agios Emilianos: Peloponnese's Riviera Offers Stunning Resorts and Villas (video) GreekReporter.com

Cephalonia Honors Its Patron Saint, Agios Gerasimos - GreekReporter.com

Cephalonia Honors Its Patron Saint, Agios Gerasimos GreekReporter.com

Agios Efstratios Island to be Heated with Renewable Energy - GreekReporter.com

Agios Efstratios Island to be Heated with Renewable Energy GreekReporter.com

Agios Silas wildfire sparks emergency response - Kathimerini

Agios Silas wildfire sparks emergency response Kathimerini

Explosion in occupied north rocks Agios Dometios - Philenews

Explosion in occupied north rocks Agios Dometios Philenews

Agios Sylas fire front improving, authorities say [PHOTOS+VIDEO] - Philenews

Agios Sylas fire front improving, authorities say [PHOTOS+VIDEO] Philenews

President Christodoulides visits Agios Dometios - Philenews

President Christodoulides visits Agios Dometios Philenews

Satellite pictures show Agios Silas fire destruction - Philenews

Satellite pictures show Agios Silas fire destruction Philenews

Tourist season starts with damaged Agios Tychonas promenade - Philenews

Tourist season starts with damaged Agios Tychonas promenade Philenews

EU Commission to fund Agios Dometios checkpoint expansion - Philenews

EU Commission to fund Agios Dometios checkpoint expansion Philenews

Explosion causes power outage in Agios Dometios - Philenews

Explosion causes power outage in Agios Dometios Philenews

Larnaca’s historic Agios Ioannis parish set for regeneration - Philenews

Larnaca’s historic Agios Ioannis parish set for regeneration Philenews

Top Agios Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant